Peptide Protocol BPHRT Research Dashboard
Protocol Active 12-Week
i

Research & Educational Use Only. This dashboard is for informational and reference purposes only. It does not constitute medical advice and does not replace the guidance of a licensed provider. Always follow your prescribed protocol.

BPHRT Research Dashboard

Peptide Protocol
12-Week Program

Complete supply tracking, reconstitution guide, dosage schedule, and handling instructions for two researchers across a full 12-week cycle.

12
Week Protocol
2
Researchers
4
Compounds
5
Dose Phases
Live Inventory Tracker
Inventory — Enter On-Hand Amounts
Researchers:
Tesamorelin
Standalone peptide
203mg
Protocol Total
10mg vials
qty
× 10mg = 120mg
12mg vials
qty
× 12mg = 12mg
On Hand: 132mg
Need 218mg
CJC-1295 / Ipamorelin
5mg+5mg blend per vial
145mg
Protocol Total
10mg blend vials
qty
× 10mg = 20mg
6mg blend vials
qty
× 6mg = 6mg
On Hand: 26mg
Need 224mg
KLOW
80mg blend per vial
728mg
Protocol Total
80mg vials
qty
× 80mg = 240mg
On Hand: 240mg
Need 240mg
Retatrutide
GLP-1/GIP/glucagon agonist
96mg
Protocol Total
48mg vials
qty
× 48mg = 96mg
20mg vials
qty
× 20mg = 40mg
On Hand: 136mg
Surplus +36mg ✓
Protocol Runway — Week-by-Week Coverage
Current Week:
Covered
Getting Low (<20% left)
Out — Need More
Hover a week dot for details
Tesamorelin
Daily · 250→2,000 mcg/day per person
132mg on hand
1
2
3
4
5
6
7
8
9
10
11
12
W1
W2
W3
W4
W5
W6
W7
W8
W9
W10
W11
W12
CJC-1295 / Ipamorelin
5 days on / 2 off · 250→2,000 mcg/day per person
26mg on hand
1
2
3
4
5
6
7
8
9
10
11
12
W1
W2
W3
W4
W5
W6
W7
W8
W9
W10
W11
W12
KLOW
Daily · 7.5→22.5 units/day per person
240mg on hand
1
2
3
4
5
6
7
8
9
10
11
12
W1
W2
W3
W4
W5
W6
W7
W8
W9
W10
W11
W12
Retatrutide
Weekly injection · 2→6 mg/week per person
136mg on hand
1
2
3
4
5
6
7
8
9
10
11
12
W1
W2
W3
W4
W5
W6
W7
W8
W9
W10
W11
W12
Supply & Preparation
Supply Status — 2 Researchers
Peptide Total Needed Action
Tesamorelin (10mg) ~35 Vials Order 22 Vials
CJC/Ipa (5/5mg) ~25 Vials Order 22 Vials
KLOW (80mg) 6 Vials Order 3 Vials
Retatrutide 100 mg 136mg On Hand

Reorder by Week 3 to avoid protocol interruption.

Reconstitution Guide

  • Tesamorelin: 3.0 mL bacteriostatic water. Use reconstituted vial within 24–48 hours.

  • CJC-1295 / Ipamorelin: 3.0 mL bacteriostatic water. Administer 5 days ON / 2 days OFF.

  • KLOW (80mg): 3.0 mL bacteriostatic water. Stable for 14–28 days refrigerated.

  • Retatrutide (48mg): 4.8 mL bacteriostatic water — 10 units = 1 mg on U-100 syringe.

  • Retatrutide (20mg): 2.0 mL bacteriostatic water — 10 units = 1 mg on U-100 syringe.

Master Dosage Schedule — Per Person
Phase Tesamorelin (Daily) CJC-1295/Ipa (5 On / 2 Off) KLOW (Daily) Retatrutide (Weekly)
Weeks 1–2 250 mcg 250 mcg each 7.5 units 2 mg
Weeks 3–4 500 mcg 500 mcg each 15 units 2 mg
Weeks 5–6 1,000 mcg 1,000 mcg each 22.5 units 4 mg
Weeks 7–8 1,500 mcg 1,500 mcg each 22.5 units 4 mg
Weeks 9–12 2,000 mcg 2,000 mcg each 15 units (Maint.) 6 mg
Handling, Storage & Supplies
Handling & Storage
  • Freeze Lyophilized: Keep powder at −20°C (−4°F) until reconstitution.
  • Refrigerate Liquid: Keep all reconstituted vials at 2–8°C (36–46°F).
  • Site Rotation: Rotate injection sites daily — abdomen, thighs, and upper arms.
  • Injection Technique: 45–90° angle, into subcutaneous tissue. Do not aspirate.
Research Supplies Needed
  • 400× Insulin Syringes (U-100, 1cc)
  • 15× Bacteriostatic Water (10 mL vials)
  • 7× Alcohol Swab Boxes (100-count)
  • 1× Approved Sharps Container